Mice with EMT6 or CT26 tumors were unresponsive to anti-Pd1 monotherapy, while the anti-Pd1 blocker resulted in obvious tumor regression and prolonged survival in mice with Klf5 KD tumors (Figures 5A and S4A). This evidence concerns the gene PDCD1 and neoplasm.